TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/14/2024
Back to search
Official data from USPTO
PROSTROLANE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PROSTROLANE
ST13
US500000079316852Class
5, 10, 35
Filing
79316852
Registration
6861578
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
11/19/2024
Trademark type
Word
Nice classes
5, 10, 35
Filing date
06/04/2021
Registration date
10/04/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/04/2022
Last transaction
11/19/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
KR
Examiner
JOHNSON, BRITTANY
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CAREGEN CO., LTD.
Representatives
Miriam D. Trudell Davis Graham & Stubbs LLC
Technical classification
Nice Classes
Class 5Class 10Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of knee joint inflammationfillers for inflammation of the knee joint; medicines for human purposesmedicinal preparations for the treatment of knee joint inflammation; pharmaceutical preparations for dermatological use; pharmaceutical preparations for the care of the skin; pharmaceutical preparations for the treatment of knee joint inflammation; non-prescription medicinesmedicinal preparations for the treatment of the skin and for dermatological use; non-prescription medicinesmedicinal preparations for the treatment of knee joint inflammation; skin care preparations for medical purposes; pharmaceutical products for the treatment of bone diseases; acne medication; implants comprising living tissue; medicines for dental purposes; prosthesis material for dental purposesporcelain for dental prostheses; filled syringes sold filled with dermatological preparations for medical purposes; pharmaceuticalspre-filled syringes used for filling wrinklesfoldsscarslips for face and body contouring and for skin rejuvenationused for treatment of inflammation of knee joints; pharmaceuticalspre-filled syringes used for skin fillers; injectable dermal fillers for use in the treatment of cellulitefoldsscarsbody contouring and for rejuvenating the skin; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient
Class 10
Implants consisting of artificial materials; implants consisting of artificial materials in gel form; implants consisting of artificial materialsa polymer gel for filling wounds and lipscontouring the face and bodyrejuvenating the skin; implants consisting of artificial materialsa polymer gel used for wrinkle and scar treatmentlipfacebody contour and skin medical apparatussyringes for injecting fillers; medical prosthesesjoint prostheses; medical apparatusinfusion and injection devices for injecting fillers; implantable subcutaneous drug delivery devices in the nature of implantable drug delivery ports
Class 35
Retail store services featuring chemical preparations for use in industry; wholesale store services featuring chemical preparations for use in industry; sales agency servicesretail services by direct solicitation by sales agents in the field of chemical preparations for use in industry; retail store services featuring medical apparatus and instruments other than for dental purposes; wholesale store services featuring medical apparatus and instruments other than for dental purposes; sales agency servicesretail services by direct solicitation by sales agents in the field of medical apparatus and instruments other than for dental purposes; retail store services featuring human and animal drugs; sales agency servicesretail services by direct solicitation by sales agents in the field of human and animal drugs; wholesale store services featuring human and animal drugs; promoting the goods and services of others by means of operating an on-line comprehensive shopping mall; business intermediary services relating to mail order by telecommunicationsorder fulfillment services; wholesale store services featuring cosmetics; retail store services featuring cosmetics; retail store services featuring biochemical additive for cosmetics manufacturing; wholesale store services featuring biochemical additive for cosmetics manufacturing; sales agency servicesretail services by direct solicitation by sales agents in the field of biochemical additive for cosmetics manufacturing; retail store services featuring peptide for cosmetics manufacturing; wholesale store services featuring peptide for cosmetics manufacturing; sales agency servicesretail services by direct solicitation by sales agents in the field of peptide for cosmetics manufacturing; sales agency servicesretail services by direct solicitation by sales agents in the field of cosmetics
Publications
History of USPTO decisions and trademark events.
29 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/14/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/14/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/14/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/20/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/27/2023
FIMP
FINAL DISPOSITION PROCESSED
01/27/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/04/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/04/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/04/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/19/2022
PUBO
PUBLISHED FOR OPPOSITION
07/19/2022
GPNX
NOTIFICATION PROCESSED BY IB
07/18/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/29/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/29/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/29/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/14/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/03/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/03/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/03/2022
RFNT
REFUSAL PROCESSED BY IB
04/18/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/29/2022
RFRR
REFUSAL PROCESSED BY MPU
03/29/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/26/2022
CNRT
NON-FINAL ACTION WRITTEN
02/25/2022
DOCK
ASSIGNED TO EXAMINER
02/22/2022
MAFR
APPLICATION FILING RECEIPT MAILED
08/07/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/03/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/29/2021
Continuous trademark protection
Get notified about every new filing that threatens PROSTROLANE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.